We provide you with 20 years of free, institutional-grade data for VYNE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VYNE. Explore the full financial landscape of VYNE stock.
| Reported Date | CIK | Ticker | Type |
|---|
VYNE Therapeutics Inc(NASDAQ:VYNE) 
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age...
Website: http://www.vynetherapeutics.com
Founded: 2003
CEO: David Domzalski
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about VYNE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.